GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Krsnaa Diagnostics Ltd (BOM:543328) » Definitions » YoY EBITDA Growth

Krsnaa Diagnostics (BOM:543328) YoY EBITDA Growth : 22.66% (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Krsnaa Diagnostics YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Krsnaa Diagnostics's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was 22.66%.

Krsnaa Diagnostics's EBITDA per Share for the three months ended in Mar. 2025 was ₹17.49.


Krsnaa Diagnostics YoY EBITDA Growth Historical Data

The historical data trend for Krsnaa Diagnostics's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Krsnaa Diagnostics YoY EBITDA Growth Chart

Krsnaa Diagnostics Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
YoY EBITDA Growth
Get a 7-Day Free Trial 448.29 -57.49 -9.97 12.46 33.48

Krsnaa Diagnostics Quarterly Data
Mar19 Mar20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.38 38.63 47.46 29.62 22.66

Krsnaa Diagnostics YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Krsnaa Diagnostics's YoY EBITDA Growth for the fiscal year that ended in Mar. 2025 is calculated as:

YoY EBITDA Growth (A: Mar. 2025 )
=(EBITDA per Share (A: Mar. 2025 )-EBITDA per Share (A: Mar. 2024 ))/ | EBITDA per Share (A: Mar. 2024 ) |
=(65.469-49.046)/ | 49.046 |
=33.48 %

Krsnaa Diagnostics's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

YoY EBITDA Growth (Q: Mar. 2025 )
=(EBITDA per Share (Q: Mar. 2025 )-EBITDA per Share (Q: Mar. 2024 )) / | EBITDA per Share (Q: Mar. 2024 )) |
=(17.487-14.256)/ | 14.256 |
=22.66 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Krsnaa Diagnostics YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Krsnaa Diagnostics's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Krsnaa Diagnostics Business Description

Traded in Other Exchanges
Address
S.No. 243, A-Hissa No. 6, CTS No. 4519, 4519/1, Near Chinchwad Station, Chinchwad, Taluka - Haveli, Pune, MH, IND, 411 019
Krsnaa Diagnostics Ltd is a diagnostic services provider, both in Radiology and Pathology. It offers a wide range of diagnostic services such as imaging/radiology services, routine clinical laboratory tests, pathology, and tele-radiology services to private and public hospitals, medical colleges, and community health centres. The company's operations predominantly relate to providing Radiology and Pathology services for X Ray, CT Scan, MRI, Mammography, Tele- Reporting Services, and all type of Blood and Urine Investigation.

Krsnaa Diagnostics Headlines

No Headlines